Institution statistics

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. - United Kingdom 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:> 1000
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:600-700
Networking Rank (Reputation):300-400
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:700-800
Total Project Funding:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 48
As coordinator: 0
As participant: 47
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 29.789.749 0 3
2019 0 113.210.219 606.345 10
2018 0 81.343.241 0 6
2017 0 41.375.516 323.750 6
2016 0 100.045.313 77.281 4
2015 0 24.408.946 773.288 3
2012 0 3.935.114 280.861 1
2011 0 11.982.403 9.000 1
2010 0 2.912.936 659.502 1
2009 0 5.057.750 389.058 1
2008 0 15.236.528 1.356.884 4
2007 0 2.850.851 285.085 1
2006 0 2.347.496 167.678 1
2005 162.448 22.498.527 948.127 1 2
2004 0 18.490.000 834.211 2
2002 0 997.545 199.509 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA17
JANSSEN PHARMACEUTICA NV13
ELI LILLY AND COMPANY LIMITED11
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE11
KATHOLIEKE UNIVERSITEIT LEUVEN11
PFIZER LIMITED11
NOVO NORDISK9
UCB BIOPHARMA9
F HOFFMANNLA ROCHE8
KAROLINSKA INSTITUTE8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER7
STICHTING KATHOLIEKE UNIVERSITEIT7
THE UNIVERSITY OF MANCHESTER7
BAYER AKTIENGESELLSCHAFT6
SANOFIAVENTIS DEUTSCHLAND6
ACADEMISCH ZIEKENHUIS GRONINGEN5
ASTRAZENECA AB5
EUROPEAN PATIENTS' FORUM5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KING'S COLLEGE LONDON5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT5
UNIVERSITE DE GENEVE5
UNIVERSITE LIBRE DE BRUXELLES5
UNIVERSITY COLLEGE LONDON5
UNIVERSITY OF COPENHAGEN5
ABBVIE INC4
ACADEMISCH ZIEKENHUIS LEIDEN4
BAYER4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
CONSIGLIO NAZIONALE DELLE RICERCHE4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
MERCK SHARP & DOHME CORP4
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON4
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN4
SANOFIAVENTIS4
TECHNISCHE UNIVERSITAET DRESDEN4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
UNIVERSITEIT MAASTRICHT4
UPPSALA UNIVERSITET4
VTT TECHNICAL RESEARCH CENTRE OF FINLAND4
ASTRAZENECA3
BRISTOLMYERS SQUIBB COMPANY CORP3
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
DANMARKS TEKNISKE UNIVERSITET3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FUNDACIO INSTITUT DE CIENCIES FOTONIQUES3
KUNGLIGA TEKNISKA HOEGSKOLAN3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
OSPEDALE PEDIATRICO BAMBINO GESU3
REGION HOVEDSTADEN3
RIJKSUNIVERSITEIT GRONINGEN3
TAKEDA DEVELOPMENT CENTRE EUROPE3
TARTU ULIKOOL3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITA DEGLI STUDI DI SIENA3
UNIVERSITAET ULM3
UNIVERSITAET ZUERICH3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITEIT GENT3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF LEEDS3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF SOUTHAMPTON3
ABBVIE DEUTSCHLAND GMBH & CO KG2
ACADEMIC MEDICAL CENTRE AMSTERDAM2
AMGEN LIMITED2
ASTELLAS PHARMA EUROPE BV2
BAYER PHARMA2
BEACTICA THERAPEUTICS AB2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER DE LUXEMBOURG2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY2
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CHALMERS TEKNISKA HOEGSKOLA AB2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
COVANCE LABORATORIES2
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E V2
DEGUSSA2
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN AIDS TREATMENT GROUP EV2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
Constancy:

Total number of partners:1096

Partner loyalty:
Frequent Partner: (> 2 projects): 356
Rare Partner: 740

Frequent / Rare Partner Ratio: 0.48

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS9
BIOLOGICAL SCIENCES9
SOCIAL AND ECONOMIC CONCERNS6
INDUSTRY AND TECHNOLOGY3
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69428
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00026
2019-12-01Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities UBIMOTIFparticipant4.147.22311
2019-11-01Collaboration for Prevention and Treatment of MDR Bacterial Infections COMBINEparticipant8.000.00011
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTparticipant3.429.2176
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Multiphoton Microscopy and Ultrafast Spectroscopy: Imaging meets Quantum MUSIQparticipant4.034.44716
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-01-01NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients NECESSITYparticipant8.200.00026
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2018-01-01Light-driven sustainable biocatalysis training network PhotoBioCatparticipant3.029.06719
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-03-01Directed Protein Evolution for Synthetic Biology and Biocatalysis ES-Catparticipant3.827.03119
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01INternational Smart Collaborative Open-access hybrid Printed Electronics pilot line InSCOPEparticipant7.998.65211
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-04-01Graphene-based disruptive technologies GrapheneCore1participant89.000.000186
2016-03-01FRAGments training NETwork FRAGNETparticipant3.842.48213
2016-03-01New Diagnostics for Infectious Diseases: “ND4ID” ND4IDparticipant3.860.50823
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01The next generation epigenetic medicine for inflammation EPIMACparticipant1.294.7852
2015-01-01Robust and affordable process control technologies for improving standards and optimising industrial operations ProPATparticipant5.484.16117
2012-01-01Novel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic Reviews MEDIASRESparticipant3.935.11410
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2010-01-01Methods in Neuroimaging NeuroPhysicsparticipant2.912.9364
2009-12-01Synapses: from molecules to higher brain function and diseases SYMBADparticipant5.057.75013
2008-12-01Promotion of plasticity as a treatment for neurodegenerative conditions PLASTICISEparticipant5.199.44516
2008-09-01New molecular purification technology for pharmaceutical production NEMOPURparticipant2.937.8339
2008-06-01Computational prediction of drug cardiac toxicity PREDICTparticipant4.100.0009
2008-06-01IBD: proteases offer new targets for drug discovery IPODDparticipant2.999.25012
2007-01-01Systems biology strategies and metabolome engineering for the enhanced production of recombinant proteins in streptomyces STREPTOMICSparticipant2.850.85110
2006-04-01European graduate school of Neuroscience EURONparticipant2.347.49614
2005-11-07Interactions between adrenal steroids and beta amyloid in the regulation of neural stem cells ASBANSCcoordinator162.4481
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
2005-02-01Integrated Multiscale Process Units with Locally Structured Elements IMPULSEparticipant10.500.00021
2004-07-30Data Grids for Process and Product Development using Numerical Simulation and Knowledge Discovery SIMDATparticipant11.000.00025
2004-01-01GENOME-BASED THERAPEUTIC DRUGS FOR DEPRESSION (GENDEP) GENDEPparticipant7.490.00019
2002-09-01Orexins / hypocretins - new targets for therapeutic control of feeding and sleeping disorders (OREXINS) OREXINSparticipant997.5455

Alias institution names:
  • GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum